REFERENCES
1. Richards MA. The national awareness and early diagnosis initiative in england: assembling the evidence. Br J Cancer 2009;101:S1-4.
2. Moodley J, Walter FM, Scott SE, Mwaka AM. Towards timely diagnosis of symptomatic breast and cervical cancer in South Africa. S Afr Med J 2018;108:803-4.
3. Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. Cancer Statistics Review of Breast Cancer in All Races, Females, by SEER Summary Stage 2000. SEER .
4. Tørring ML, Frydenberg M, Hansen RP, Olesen F, Vedsted P. Evidence of increasing mortality with longer diagnostic intervals for five common cancers: a cohort study in primary care. Eur J Cancer 2013;49:2187-98.
5. Jung SY, Sereika SM, Linkov F, Brufsky A, Weissfeld JL, et al. The effect of delays in treatment for breast cancer metastasis on survival. Breast Cancer Res Treat 2011;130:953-64.
6. Chintamani, Tuteja A, Khandelwal R, Tandon M, Bamal R, et al. Patient and provider delays in breast cancer patients attending a tertiary care centre: a prospective study. JRSM Short Rep 2011;2:76.
7. Olivotto IA, Gomi A, Bancej C, Brisson J, Tonita J, et al. Influence of delay to diagnosis on prognostic indicators of screen-detected breast carcinoma. Cancer 2002;94:2143-50.
8. Richards MA, Smith P, Ramirez AJ, Fentiman IS, Rubens RD. The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer 1999;79:858-64.
9. Ramirez AJ, Westcombe AM, Burgess CC, Sutton S, Littlejohns P, et al. Factors predicting delayed presentation of symptomatic breast cancer: a systematic review. Lancet 1999;353:1127-31.
10. Arndt V, Stürmer T, Stegmaier C, Ziegler H, Dhom G, et al. Patient delay and stage of diagnosis among breast cancer patients in Germany - a population based study. Br J Cancer 2002;86:1034-40.
11. Afzelius P, Zedeler K, Sommer H, Mouridsen HT, Blichert-Toft M. Patient’s and doctor’s delay in primary breast cancer. Prognostic implications. Acta Oncol 1994;33:345-51.
12. Mor V, Masterson-Allen S, Goldberg R, Guadagnoli E, Wool MS. Prediagnostic symptom recognition and help-seeking among cancer patients. J Community Health 1990;15:253-66.
13. Lin YL, Qin YC, Tang LY, Liao YH, Zhang W, et al. Patient and care delays of breast cancer in China. Cancer Res Treat 2018; doi: 10.4143/crt.2018.386.
14. Olesen F, Hansen RP, Vedsted P. Delay in diagnosis: the experience in Denmark. Br J Cancer 2009;101 Suppl 2:S5-8.
15. Weller D, Vedsted P, Rubin G, Walter FM, Emery J, et al. The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br J Cancer 2012;106:1262-7.
16. Walter F, Webster A, Scott S, Emery J. The Andersen model of total patient delay: a systematic review of its application in cancer diagnosis. J Health Serv Res Policy 2012;17:110-8.
17. Andersen BL, Cacioppo JT. Delay in seeking a cancer diagnosis: delay stages and psychophysiological comparison processes. Br J Soc Psychol 1995;34:33-52.
18. de Nooijer J, Lechner L, de Vries H. A qualitative study on detecting cancer symptoms and seeking medical help; an application of Andersen’s model of total patient delay. Patient Educ Couns 2001;42:145-57.
19. Pack GT, Gallo JS. The culpability for delay in the treatment of cancer. Am J Cancer 1938;33:443-62.
20. Hansen RP, Vedsted P, Sokolowski I, Søndergaard J, Olesen F. Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients. BMC Health Serv Res 2011;11:284.
21. Rossi S, Cinini C, Di Pietro C, Lombardi CP, Crucitti A, et al. Diagnostic delay in breast cancer: correlation with disease stage and prognosis. Tumori 1990;76:559-62.
22. Park CS, Jung NY, Kim K, Jung HS, Sohn KM, et al. Detection of breast cancer in asymptomatic and symptomatic groups using computer-aided detection with full-field digital mammography. J Breast Cancer 2013;16:322-8.
23. Narod SA, lqbal J, Jakubowska A, Huzarski T, Sun P, et al. Are two-centimeter breast cancers large or small? Curr Oncol 2013;20:205-11.
24. Oeffinger KC, Fontham ETH, Etzioni R, Herzig A, Michaelson JS, et al. Breast cancer screening for women at average risk: 2015 guideline update from the American cancer society. JAMA 2015;314:1599-614.
25. Mango V, Bryce Y, Morris EA, Gianotti E, Pinker K. Commentary ACOG practice bulletin July 2017: breast cancer risk assessment and screening in average-risk women. Br J Radiol 2018;91:20170907.
26. Kirsch VA, Chiarelli AM, Edwards SA, O’Malley FP, Shumark RS, et al. Tumor characteristics associated with mammographic detection of breast cancer in the ontario breast screening program. J Natl Cancer Inst 2011;103:942-50.
27. Lopez JK, Bassett LW. Invasive lobular carcinoma of the breast: spectrum of mammographic, US, and MR imaging findings. Radio-Graphics 2009;29:165-76.
28. Rosen PP. Invasive lobular cancer. In: Rosen PP, editor. Rosen’s Pathology of the Breast. New York: Lippincott Williams & Wilkins; 2001. pp. 629-37.
29. Kwok C, Ogunsiji O, Lee CF. Validation of the breast cancer screening beliefs questionnaire among African Australian women. BMC Public Health 2016;16:117.
30. Unger-Saldaña K, Peláez-Ballestas I, Infante-Castañeda C. Development and validation of a questionnaire to assess delay in treatment for breast cancer. BMC Cancer 2012;12:626.
31. Gorini A, Mazzocco K, Gandini S, Munzone E, McVie G, et al. Development and psychometric testing of a breast cancer patient-profiling questionnaire. Breast Cancer (Dove Med Press) 2015;7:133-46.
32. Linsell L, Forbes LJ, Burgess C, Kapari M, Thurnham A, et al. Validation of a measurement tool to assess awareness of breast cancer. Eur J Cancer 2010;46:1374-81.
33. Leventhal H, Brissette I, Leventhal EA. The common-sense model of self-regulation of health and illness (Ch 3). In: Cameron LD, Leventhal H, editors. The self-regulation of health and illness behaviour. London: Routledge; 2003. pp. 42-65.
34. O’Mahony M, Hegarty J. Factors influencing women in seeking help from a health care professional on self discovery of a breast symptom, in an Irish context. J Clin Nurs 2009;18:2020-9.
35. Ristvedt SL, Trinkaus KM. Psychological factors related to delay in consultation for cancer symptoms. Psychooncology 2005;14:339-50.
36. O’Mahony M, Hegarty J, Mc Carthy G. Women’s help seeking behaviour for self discovered breast cancer symtoms. Eur J Oncol Nurs 2011;15:410-8.
37. Brouha XD, Tromp DM, de Leeuw JR, Hordijk GJ, Winnubst JA. Laryngeal cancer patients: analysis of patient delay at different tumor stages. Head Neck 2005;27:289-95.
38. Brouha XD, Tromp DM, Hordijk GJ, Winnubst JA, de Leeuw JR. Oral and pharyngeal cancer: analysis of patient delay at different tumor stages. Head Neck 2005;27:939-45.
39. Bairati I, Fillion L, Meyer FA, Héry C, Larochelle M. Women’s perceptions of events impeding or facilitating the detection, investigation and treatment of breast cancer. Eur J Cancer Care 2006;15:183-93.
40. Facione NC, Miaskowski C, Dodd MJ, Paul SM. The self-reported likelihood of patient delay in breast cancer: new thoughts for early detection. Prev Med 2002;34:397-407.
41. Taber JM, Leyva B, Persoskie A. Why do people avoid medical care? A qualitative study using national data. J Gen Intern Med 2015;30:290-7.
42. Zafar SY, Peppercorn JM, Schrag D, Taylor DH, Goetzinger AM, et al. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient’s experience. Oncologist 2013;18:381-90.
43. Funch D, Francis A. The role of patient delay in the evaluation of breast self-examination. J Psychosocial Oncol 1985;2:31-9.
44. Carter TI, Reily JJ. Missed opportunities: clinical antecedents in the diagnosis of advanced breast cancer. Ann Surg Oncol 2012;19:2782-5.
